See more news releases in: Medical Pharmaceuticals
VIDEO from Roche Pharmaceuticals Available on thenewsmarket.com: Study Showed Rituxan/MabThera for Initial Use Followed by Continued Use Delayed Need for Additional Therapy in People with Asymptomatic Follicular Lymphoma
NEW YORK, Dec. 5, 2010 /PRNewswire/ -- See video from Roche Pharmaceuticals at:
Roche announced positive data from a Phase III study of Rituxan/MabThera (rituximab) in patients with advanced follicular lymphoma who did not have symptoms of disease (asymptomatic disease). Phase III study showed Rituxan/MabThera for initial use followed by continued use delayed need for additional therapy in people with asymptomatic follicular lymphoma, a common type of blood cancer. Rituxan/MabThera decreased the risk of needing later treatment with chemotherapy or radiotherapy by 80%. Available video includes mode of action, animations, product shots as well as soundbites.
About thenewsmarket.com
thenewsmarket.com delivers free broadcast- and streaming-quality video and multimedia content directly to media around the world, 24/7. More than 25,000 media outlets in 190+ countries use thenewsmarket.com, including the AP, BBC, CNBC, CNN, France 24, N24, nytimes.com, RAI, TVE, ZDF and a lot more.
Registered journalists can preview and download video, audio, text, graphics and photos at http://www.thenewsmarket.com.
If not already registered, please take a moment to sign up - registration is quick, easy and free: http://www.thenewsmarket.com/registration
We are always happy to receive your feedback, suggestions or enquiries. Email us at journalisthelp@thenewsmarket.com
Story Id: 20726
SOURCE thenewsmarket.com
Back to top
RELATED LINKS
http://www.thenewsmarket.com
Custom Packages
Browse our custom packages or build your own to meet your unique communications needs.
PR Newswire Membership
Fill out a PR Newswire membership form or contact us at (888) 776-0942.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.
Featured Video
More in These Categories
Journalists and Bloggers
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
Free Investing Newsletter from Investor Uprising!
Learn to navigate the world's financial system and profit from leading companies.
Register for Investor Uprising, the people's investment site, for a free weekly newsletter, information, education and premium research including our latest IU Confidential Report - "All That Glitters: The Ultimate Gold Report".